Condition
Hemophilia
Hemophilia is an inherited bleeding disorder in which too little of a clotting protein, factor VIII or factor IX, means bleeding lasts longer, often into joints and muscles. Desmopressin has the strongest evidence, and studies found it raised factor VIII activity two- to four-fold, enough for minor surgery in mild hemophilia A without factor concentrates. Those findings concern mild hemophilia A; vitamin D and calcium for bone health have only moderate evidence.
Sources: PMID 15227644
- Supplements studied
- 0
- Medicines and peptides
- 1
- Graded outcomes
- 2
No supplement studies yetWe haven’t found supplement studies for Hemophilia. The medicines and peptides studied for it are listed below.
Prescription medicines and peptides studied, for context
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| von Willebrand Factor Levels Up to 4-fold increase in vWF levels. Effective for von Willebrand disease Type I and some Type II variants. | Improves (the measure goes up) | Large effect | 33 studies | |||
Studies that measured von willebrand factor levels
| ||||||
| Factor VIII Levels 2-4 fold increase in factor VIII coagulant activity, allowing minor surgery in mild hemophilia A without factor concentrates. | Improves (the measure goes up) | Large effect | 22 studies | |||
Key findings
- von Willebrand Factor LevelsImproves (the measure goes up)
- Factor VIII LevelsImproves (the measure goes up)
The Hemophilia Supportive Care protocol
2 primary supplements · 7 supporting supplements
Studies cited
54 studies from PubMed
- A Review of Desmopressin Use in Bleeding Disorders: An Unsung Hero?
- Lithium-induced Nephrogenic Diabetes Insipidus with Efficacy of Desmopressin in Combination with Thiazide Diuretics and Non-steroidal Anti-inflammatory Drugs: A Case Report with a Review of the Literature.
- Desmopressin, Misoprostol, nor Carboprost Affect Platelet Aggregability Following Traumatic Brain Injury and Aspirin.
- Desmopressin use in major cardiac surgery is associated with renal impairment: a retrospective single-center analysis.
- Safety and efficacy of desmopressin (DDAVP) in preventing hematoma expansion in intracranial hemorrhage associated with antiplatelet drugs use: A systematic review and metaanalysis.
- Desmopressin (DDAVP) use in patients with von Willebrand disease: A single-centre retrospective review of test response and clinical outcomes.
- Infection with SARS-CoV-2 may alter the half-life of desmopressin (DDAVP) in patients with central diabetes insipidus.
- Desmopressin Stimulates Nitric Oxide Production in Human Lung Microvascular Endothelial Cells.
- Desmopressin in canine mammary carcinoma: Comments on the importance of the administration route.
- Safety of renal biopsy bleeding prophylaxis with desmopressin.
- Effect of Desmopressin on Platelet Dysfunction During Antiplatelet Therapy: A Systematic Review.
- Desmopressin and nocturnal voiding dysfunction: Clinical evidence and safety profile in the treatment of nocturia.
- Desmopressin in non-severe haemophilia A: Test-response and clinical outcomes in a single Canadian centre review.
- Diabetes insipidus during pregnancy.
- Diabetes insipidus and pregnancy.
- The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models.
- Desmopressin to Prevent Rapid Sodium Correction in Severe Hyponatremia: A Systematic Review.
- A systematic review of the efficacy and safety of desmopressin for nocturia in adults.
- Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults.
- Severe signs of hyponatremia secondary to desmopressin treatment for enuresis: a systematic review.
- Efficacy and safety of desmopressin for treatment of nocturia: a systematic review and meta-analysis of double-blinded trials.
- The use of desmopressin in acquired haemophilia A: a systematic review.
- Adenotonsillectomy in patients with desmopressin responsive mild bleeding disorders: a review of the literature.
- The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis.
- Desmopressin 30 years in clinical use: a safety review.
- The use of desmopressin as a hemostatic agent: a concise review.
- Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations
- Desmopressin: a nightly option for nocturnal enuresis
- Desmopressin : safety considerations in patients with chronic renal disease.
- Desmopressin and other synthetic vasopressin analogues in cancer treatment.
- Use of desmopressin (DDAVP) during early pregnancy in factor VIII-deficient women.
- Desmopressin in central diabetes insipidus
- The risk of hyponatremia in older adults using desmopressin for nocturia: a systematic review and meta-analysis.
- Desmopressin (DDAVP)-induced pseudotumor cerebri.
- Desmopressin for nocturnal enuresis in children
- Desmopressin in hemophilia A and von Willebrand's disease
- Desmopressin usage in elective cardiac surgery.
- Desmopressin (DDAVP) in the treatment of bleeding disorders
- Desmopressin in the treatment of nocturnal enuresis in children: a multicenter study
- Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years
- Intranasal desmopressin-associated hyponatremia: a case report and literature review.
- The use of desmopressin (DDAVP) in hemostatic therapy
- Desmopressin side effects.
- Side effects and complications of treatment with desmopressin for enuresis.
- Desmopressin acetate in cardiac surgery: a double-blind, randomized study.
- Efficacy, safety, and dosing of desmopressin for nocturnal enuresis in Europe.
- Desmopressin for diabetes insipidus, hemostatic disorders and enuresis
- Use of desmopressin in the management of aspirin-related and intractable haemorrhage after cardiopulmonary bypass.
- Clinical experience with desmopressin: efficacy and safety in central diabetes insipidus and other conditions.
- Management of cranial diabetes insipidus with oral desmopressin (DDAVP).
- Desamino-D-arginine-vasopressin (DDAVP) in Alzheimer's disease.
- Desmopressin
- Vasopressin analog DDAVP in the treatment of diabetes insipidus
- Desmopressin (DDAVP) in diabetes insipidus.